Avrupa Yatirim Holding (IBSE:AVHOL) - Share price, News & Analysis

AVHOL fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	4/6
Financial Health	5/6
Dividends	0/6

AVHOL Stock Overview

Avrupa Yatirim Holding A.S. engages in healthcare and telecommunication services.

Rewards

Earnings grew by 1191.7% over the past year

Risk Analysis

High level of non-cash earnings

Shareholders have been diluted in the past year

Does not have meaningful revenue (TRY49M)

Does not have a meaningful market cap (TRY284M)

Avrupa Yatirim Holding Competitors

Lokman Hekim Engürüsag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhüt

IBSE:LKMNH

₺588.2m

Nasmed Özel Saglik Hizmetleri Ticaret Anonim Sirketi

IBSE:EGEPO

₺1.3b

MLP Saglik Hizmetleri

IBSE:MPARK

₺6.8b

Seyitler Kimya Sanayi

IBSE:SEYKM

₺277.6m

Price History & Performance

Summary of all time highs, changes and price drops for Avrupa Yatirim Holding
Historical stock prices
Current Share Price	₺7.62
52 Week High	₺7.80
52 Week Low	₺4.51
Beta	-0.16
1 Month Change	35.11%
3 Month Change	40.33%
1 Year Change	32.29%
3 Year Change	292.78%
5 Year Change	372.31%
Change since IPO	170.21%

Shareholder Returns

	AVHOL	TR Healthcare	TR Market
7D	6.1%	-2.6%	-4.5%
1Y	32.3%	-26.4%	54.7%

Return vs Industry: AVHOL exceeded the TR Healthcare industry which returned -28% over the past year.

Return vs Market: AVHOL underperformed the TR Market which returned 55.1% over the past year.

Price Volatility

Is AVHOL's price volatile compared to industry and market?
AVHOL volatility
AVHOL Average Weekly Movement	4.2%
Healthcare Industry Average Movement	5.5%
Market Average Movement	6.1%
10% most volatile stocks in TR Market	8.7%
10% least volatile stocks in TR Market	4.2%

Stable Share Price: AVHOL is less volatile than 75% of TR stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: AVHOL's weekly volatility (4%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1998	291	Ramazan Telli	https://avrupayatirimholding.com.tr

Avrupa Yatirim Holding A.S. engages in healthcare and telecommunication services. It operates, equips, and leases private hospitals, medical centers, dialysis centers, medical analysis and x-ray laboratories, and other healthcare facilities. The company also sells, transfers, and leases communication equipment comprising telephone, telex, and fax, as well as invests in domestic and foreign companies

Avrupa Yatirim Holding Fundamentals Summary

How do Avrupa Yatirim Holding's earnings and revenue compare to its market cap?
AVHOL fundamental statistics
Market Cap	₺283.85m
Earnings (TTM)	₺7.80m
Revenue (TTM)	₺48.61m

36.4x

P/E Ratio

5.8x

P/S Ratio

Is AVHOL overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
AVHOL income statement (TTM)
Revenue	₺48.61m
Cost of Revenue	₺33.73m
Gross Profit	₺14.88m
Other Expenses	₺7.09m
Earnings	₺7.80m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	0.21
Gross Margin	30.62%
Net Profit Margin	16.04%
Debt/Equity Ratio	1.3%

How did AVHOL perform over the long term?

See historical performance and comparison

We’ve recently updated our valuation analysis.

Valuation

Is AVHOL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AVHOL?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for AVHOL. This is calculated by dividing AVHOL's market cap by their current preferred multiple.
What is AVHOL's n/a Ratio?
n/a Ratio	0x
n/a	n/a
Market Cap	₺283.85m

AVHOL key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	6.1x
Enterprise Value/EBITDA	23.9x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does AVHOL's PE Ratio compare to its peers?

AVHOL PE Ratio vs Peers

The above table shows the PE ratio for AVHOL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	PE	Estimated Growth	Market Cap
Peer Average	26.7x
LKMNH Lokman Hekim Engürüsag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhüt	6.8x	n/a	₺588.2m
EGEPO Nasmed Özel Saglik Hizmetleri Ticaret Anonim Sirketi	74.1x	n/a	₺1.3b
MPARK MLP Saglik Hizmetleri	17.2x	27.1%	₺6.8b
SEYKM Seyitler Kimya Sanayi	8.7x	n/a	₺277.6m
AVHOL Avrupa Yatirim Holding	36.4x	n/a	₺283.8m

Forward PE

Price-To-Earnings vs Peers: AVHOL is expensive based on its Price-To-Earnings Ratio (36.4x) compared to the peer average (26.7x).

Price to Earnings Ratio vs Industry

How does AVHOL's PE Ratio compare vs other companies in the Asian Healthcare Industry?

Price-To-Earnings vs Industry: AVHOL is expensive based on its Price-To-Earnings Ratio (36.4x) compared to the TR Healthcare industry average (17.3x)

Price to Earnings Ratio vs Fair Ratio

What is AVHOL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AVHOL PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	36.4x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate AVHOL's Price-To-Earnings Fair Ratio for valuation analysis.

Share Price vs Fair Value

What is the Fair Price of AVHOL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate AVHOL's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate AVHOL's fair value for valuation analysis.

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate AVHOL's PEG Ratio to determine if it is good value.

Discover undervalued companies

Future Growth

How is Avrupa Yatirim Holding forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

18.1%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Avrupa Yatirim Holding has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Discover growth companies

Check out Avrupa Yatirim Holding's track record over time to understand how much the company has returned to shareholders and its earnings growth rate in the past.

Past Performance

How has Avrupa Yatirim Holding performed over the past 5 years?

Past Performance Score

4/6

Past Performance Score 4/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

68.4%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: AVHOL has a high level of non-cash earnings.

Growing Profit Margin: AVHOL's current net profit margins (16%) are higher than last year (3.3%).

Past Earnings Growth Analysis

Earnings Trend: AVHOL has become profitable over the past 5 years, growing earnings by 68.4% per year.

Accelerating Growth: AVHOL's earnings growth over the past year (1191.7%) exceeds its 5-year average (68.4% per year).

Earnings vs Industry: AVHOL earnings growth over the past year (1191.7%) exceeded the Healthcare industry 169.5%.

Return on Equity

High ROE: AVHOL's Return on Equity (9.7%) is considered low.

Discover strong past performing companies

Financial Health

How is Avrupa Yatirim Holding's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage

Financial Position Analysis

Short Term Liabilities: AVHOL's short term assets (TRY48.9M) exceed its short term liabilities (TRY21.2M).

Long Term Liabilities: AVHOL's short term assets (TRY48.9M) exceed its long term liabilities (TRY5.1M).

Debt to Equity History and Analysis

Debt Level: AVHOL has more cash than its total debt.

Reducing Debt: AVHOL's debt to equity ratio has reduced from 125.4% to 1.3% over the past 5 years.

Debt Coverage: AVHOL's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: AVHOL earns more interest than it pays, so coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies

Dividend

What is Avrupa Yatirim Holding current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate AVHOL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate AVHOL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if AVHOL's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AVHOL's dividend payments have been increasing.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as AVHOL has not reported any payouts.

Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

CEO

Ramazan Telli (45 yo)

no data

Tenure

Mr. Ramazan Burak Telli serves as General Manager and Chairman of the Board of Directors of Avrupa Yatirim Holding A.S.

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.2%.

Data	Last Updated (UTC time)
Company Analysis	2022/06/30 00:00
End of Day Share Price	2022/06/30 00:00
Earnings	2022/03/31
Annual Earnings	2021/12/31